Featured Content

Retina

Gene Therapy for Inherited Retinal Disease

A look at the results ophthalmic researchers and companies are generating as they explore genetic therapies for these difficult-to-treat conditions.
Glaucoma

The Best Approach for Narrow-Angle Patients

The age of the patient is one of the many factors to consider when treating patients with narrow angles, experts say.
Glaucoma

The Glaucoma Medication Pipeline, 2022

Catching up on the status of four eye drops being developed to target the disease.
Practice Management

Update: Private Equity in Ophthalmology

Many surgeons say they’ve had a positive experience—but proceeding with caution is advised.
Telemedicine

Look But Don't Touch

Musings on life, ophthalmology and the practice of medicine.

Review of Ophthalmology Online eNewsletter

Continuing Medical Education

  • Optimal Diagnosis and Treatment of Blepharoptosis

    Optimal Diagnosis and Treatment of Blepharoptosis

    In this CME Monograph from MedEdicus, a panel of expert ophthalmologists will review the common causes of ptosis and traditional therapies for ptosis correction. The panel will also review the clinical data for oxymetazoline 0.1%, a new topical medical therapy approved for ptosis treatment. In addition, a series of cases will be discussed to demonstrate the systematic evaluation of patients with ptosis and the development of individualized treatment plans.
     
  • A Closer Look: Emerging Medical Therapies for Presbyopia

    A Closer Look: Emerging Medical Therapies for Presbyopia

    This CME activity provides an overview of age-related loss of accommodation as well as several of the emerging topical therapies for presbyopia that are under investigation. Perspectives on selection of prospective patients as well as potential opportunities for practice growth are also discussed.
  • Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat

    Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat

    A panel of experts discuss the importance of early detection of neurotrophic keratitis and the latest data on available treatment options in this CME activity.
  • Breaking New Ground: Reducing Treatment Burden in Neovascular AMD

    Breaking New Ground: Reducing Treatment Burden in Neovascular AMD

    This CME monograph, based on an expert roundtable discussion, will present challenging cases in nAMD along with the latest clinical trial data and perspectives on how the newest advances in nAMD treatment can be translated to the real world.